Owkin
French artificial intelligence company
Updates & Highlights
mobihealthnews.com · 4 days ago
Owkin licenses AI scientist, patient data to Servier for oncology research
hpcwire.com · 7 days ago
Owkin to License K Pro and Multimodal Data to Servier to Advance Oncology Research
Fierce Biotech · 7 days ago
Owkin, Servier ink oncology R&D deal to guide discovery and trial design
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Owkin?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentOwkin licenses AI scientist, patient data to Servier for oncology research
Owkin licenses AI scientist, patient data to Servier for oncology research
mobihealthnews.com · 4 days ago
Owkin to License K Pro and Multimodal Data to Servier to Advance Oncology Research
Owkin to License K Pro and Multimodal Data to Servier to Advance Oncology Research
hpcwire.com · 7 days ago
Owkin, Servier ink oncology R&D deal to guide discovery and trial design
Owkin, Servier ink oncology R&D deal to guide discovery and trial design
Fierce Biotech · 7 days ago
Owkin Licenses K Pro AI Scientist And Multimodal Patient Data To Servier For Oncology Research
Owkin Licenses K Pro AI Scientist And Multimodal Patient Data To Servier For Oncology Research
Pulse 2.0 · 7 days ago
Servier Becomes Latest Company to License Owkin’s K Pro AI Scientist
Servier Becomes Latest Company to License Owkin’s K Pro AI Scientist
Contract Pharma · 7 days ago
Owkin to License K Pro and Multimodal Data to Servier to Advance Oncology Research
Owkin to License K Pro and Multimodal Data to Servier to Advance Oncology Research
Business Wire · 7 days ago
Thomas Clozel, M.D., Co-Founder and CEO of Owkin – Interview Series
Thomas Clozel, M.D., Co-Founder and CEO of Owkin – Interview Series
Unite.AI · 8 days ago
OWKIN Revenue 2023: $101.4M Est. ARR, $1B Valuation (2022)
OWKIN Revenue 2023: $101.4M Est. ARR, $1B Valuation (2022)
GetLatka · 8 days ago
Owkin Partners with Boehringer Ingelheim to Accelerate Drug Discovery with AI
Owkin Partners with Boehringer Ingelheim to Accelerate Drug Discovery with AI
SynBioBeta · 10 days ago
Boehringer Ingelheim Licenses Owkin's AI for Drug Discovery.
Boehringer Ingelheim Licenses Owkin's AI for Drug Discovery.
konsulteer.com · 14 days ago
Boehringer Ingelheim signs AI agreement with Owkin
Boehringer Ingelheim signs AI agreement with Owkin
medwatch.com · 14 days ago
Owkin licenses AI Scientist platform and multimodal patient data to Boehringer
Owkin licenses AI Scientist platform and multimodal patient data to Boehringer
The Pharma Letter · 15 days ago
Boehringer signs AI drug discovery deal with Owkin
Boehringer signs AI drug discovery deal with Owkin
pharmaphorum.com · 15 days ago
Owkin K Pro and Boehringer AI Drug Discovery
Owkin K Pro and Boehringer AI Drug Discovery
Briefs Finance · 16 days ago
Owkin lands third major pharma partner in AI deal with Boehringer Ingelheim
Owkin lands third major pharma partner in AI deal with Boehringer Ingelheim
FirstWord Pharma · 16 days ago
Boehringer Ingelheim Licenses Owkin’s K Pro AI Scientist for Accelerated Discovery in Oncology, Immunology
Boehringer Ingelheim Licenses Owkin’s K Pro AI Scientist for Accelerated Discovery in Oncology, Immunology
Contract Pharma · 16 days ago
Boehringer Ingelheim Licenses Owkin’s K Pro AI Scientist and Patient Data
Boehringer Ingelheim Licenses Owkin’s K Pro AI Scientist and Patient Data
Unite.AI · 16 days ago
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim
BioSpace · 16 days ago
Owkin, Boehringer Ingelheim ink AI drug discovery deal
Owkin, Boehringer Ingelheim ink AI drug discovery deal
PharmaLive · 16 days ago
Owkin To License K Pro AI Scientist And Multimodal Oncology And Immunology Data To Boehringer Ingelheim
Owkin To License K Pro AI Scientist And Multimodal Oncology And Immunology Data To Boehringer Ingelheim
TradingView · 16 days ago